We are live on ! Find out more
ARGS

Argos Therapeutics, Inc.
ARGS

Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

32 hedge funds and large institutions have $45.8M invested in Argos Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$12.4M
2
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
+$7.5M
3
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
+$7.44M
4
WSA
Wall Street Associates
California
+$5.18M
5
PRCM
Pine River Capital Management
Minnesota
+$2.56M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$43K +$42.6K +213 New
TRCT
27
Tower Research Capital (TRC)
New York
$19K +$18.8K +94 New
BA
28
BlackRock Advisors
Delaware
$6K +$6.2K +31 New
TDC
29
Thompson Davis & Co
Virginia
$5K +$5K +25 New
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$3K +$3K +15 New
AIG
31
American International Group
New York
$2K +$2K +10 New
Barclays
32
Barclays
United Kingdom
$1K +$1.2K +6 New
1
2

ARGS Hedge Fund Activity: Q1 2014 in Review

32 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Argos Therapeutics, Inc. (ARGS) for Q1 2014, worth a combined $45.8M.

Buyers outnumbered sellers: 32 funds opened new ARGS positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Wasatch Advisors, opening a new position worth an estimated $12.4M.

  • 32 institutional investors held Argos Therapeutics, Inc. (ARGS) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $45.8M of Argos Therapeutics, Inc. stock for Q1 2014.
  • 32 funds opened new Argos Therapeutics, Inc. positions in Q1 2014 and 0 closed out, a net change of +32 holders.
  • The largest Argos Therapeutics, Inc. buyer in Q1 2014 was Wasatch Advisors, an estimated $12.4M added.

Based on aggregated 13F filings for Q1 2014.